Profil
Peter Jarrett is Chief Technical Officer at Ocular Therapeutix, Inc. since 2024 and has been with the company since 2007.
Formerly, Dr. Jarrett was Head-Research & Development at Wyeth Holdings LLC, Vice President-Research & Development at Focal, Inc. from 1993 to 2001, and Vice President-Biomaterials Research & Development at Genzyme Corp.
from 2001 to 2007.
Education includes undergraduate studies at Connecticut College and a doctorate from The Institute of Materials Science.
Aktiva positioner av Peter Jarrett
| Företag | Position | Start |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2007-01-01 |
Tidigare kända positioner av Peter Jarrett
| Företag | Position | Slut |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | 2007-07-01 |
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures synthetic liquid surgical sealant | Teknisk/Vetenskaplig/F&U Direktör | 2001-01-01 |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Teknisk/Vetenskaplig/F&U Direktör | - |
Peter Jarretts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures synthetic liquid surgical sealant | Process Industries |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Connecticut College
Connecticut College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Institute of Materials Science
The Institute of Materials Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















